MeMed
MeMed61
About
Pricing
View pricing page ↗
What does MeMed do?
MeMed is a leading med tech and bio-convergence company focused on developing and commercializing innovative host immune response testing methods. Their mission is to translate the complex signals of the immune system into simple diagnostic insights, helping clinicians make better decisions for patients facing acute infections and inflammatory conditions.
What is MeMed's revenue?
StartupHub estimates MeMed's annual revenue at $18.2M (range $9.7M to $26.5M, 66% confidence), based on comparable companies in the sector.
What is MeMed's valuation?
StartupHub estimates MeMed's effective valuation at $826.3M (range $489.5M to $1.2B, 10% confidence), based on comparable companies in the sector.
How much funding has MeMed raised?
MeMed has raised a total of $196M in funding. The most recent round on record is Series E.
Where is MeMed headquartered?
MeMed is headquartered in Tirat Carmel, Israel.
When was MeMed founded?
MeMed was founded in 2009.
What industry does MeMed operate in?
MeMed operates in Healthcare, Blood, Diagnostics, MedTech, Biotech, Host Immune Response.
How many employees does MeMed have?
MeMed has approximately 99 people on record.
No comments yet. Be the first to share your take.